The PHAPCares Foundation, the corporate social responsibility arm of the Pharmaceutical and Healthcare Association of the Philippines (PHAP), is organizing the first-ever Seal of Excellence in Healthcare Awards for this year.
Companies that receive the PHAPCares Foundation Corporate Social Responsibility (CSR) Seal of Excellence is a testament that a company has achieved the highest distinction for its outstanding support to the programs and projects of the organization.
The seal will also be given to companies that have demonstrated exemplary initiatives that reflect sustainability and innovation in improving the lives and health of individual Filipinos and communities.
“PHAPCares has a long history of leadership when it comes to corporate citizenship. Through this first-ever awards, we aspire to recognize our Members who have been partnering with the government, various institutions and communities for a healthier and more productive Philippines. We hope to further inspire them to forge more collaborations to make sustainable health, social and economic impact on the communities,” said PHAPCares president Lotis Ramin who is also president of AstraZeneca Philippines.
Together with their partners, the Foundation will be giving out their seals of excellence in two categories—Seal of Excellence in Healthcare Awards and Seal of Excellence in Sustainability and Innovation Awards.
The Seal of Excellence in Healthcare Awards will be given to PHAPCares members who have participated or supported at least three priority programs of the foundation or participated or supported at least five activities of the foundation. The foundation programs fall under sustainable healthcare, access to medicines and emergency response and social development.
On the other hand, the Seal of Excellence in Sustainability and Innovation Awards will be given to institutions that participate in a CSR program that reflects sustainability and innovation to make healthcare accessible to Filipinos and communities.
“We are excited to launch the Awards as this is an important platform to showcase the several programs of our Members. Their efforts are consistent with our mandate to strengthen communities that may be disadvantaged by sickness, poverty, conflicts, disasters, or the pandemic,” said PHAPCares Executive Director Dr. Maria Rosarita Qujano-Siasoco.
For the sustainability and innovation awards, the program will be judged on relevance (30%); project impact (30%); use of innovation (20%) and sustainability/scalability (20%).
The submission of entries for the Seal of Excellence in Sustainability and Innovation Award is until Nov. 9. It is open to all PHAPCares Members composed of medicines and vaccines providers in the Philippines.
Since its incorporation in 2003, the organization has donated at least P1 billion worth of medicines for use of the communities and organizations. PHAPCares is also a recipient of a Presidential Citation and Gawad Kalasag for its work in health systems strengthening and in rural areas and disaster response, respectively.
